Vitamin B12 and folate: tests and interpretation

This page explains how to read tests for vitamin B12 and folate status, and how to decide whether a borderline result means true deficiency. It is written for the clinician-facing laboratory view: what each test measures, the ranges, and the combinations that matter.

Vitamin B12 (cobalamin) and folate (vitamin B9) are both cofactors in one-carbon metabolism. Both are required for DNA synthesis and normal red cell maturation, so deficiency of either produces a megaloblastic, macrocytic anaemia. B12 has a second, separate role in myelin maintenance, which is why B12 deficiency causes neuropathy and subacute combined degeneration of the spinal cord while folate deficiency does not ^[5]. The two deficiencies cannot be told apart by the blood film alone, so the laboratory panel is what separates them ^[1]. ^[6]

The key idea is this: total serum B12 is cheap and available everywhere, but it measures both active and inactive fractions and can be misleading. Active B12 (holotranscobalamin), methylmalonic acid (MMA) and homocysteine are the tests that settle the doubt, and each has a different fault line ^[1][2]. Folate status is simpler: serum folate is the first-line test, with red cell folate available when longer-term status matters ^[3]. ^[6]

Total serum vitamin B12 (cobalamin, sometimes labelled "B12"). This is the screening test. It measures B12 bound to two transport proteins: haptocorrin carries about 80 percent and transcobalamin about 20 percent. Only the transcobalamin-bound fraction, holotranscobalamin, is available to cells. A normal total can therefore look generous while the active fraction is low, and a low total can occur without tissue deficiency when haptocorrin is low ^[1].

Active B12 (serum holotranscobalamin). This measures the fraction bound to transcobalamin, the form cells can take up. It is more sensitive than total B12, less affected by haptocorrin changes, and is the recommended first test in pregnancy ^[1][2]. It costs more and is less widely available ^[1].

Methylmalonic acid (MMA). B12 is the cofactor for methylmalonyl-CoA mutase, so when tissue B12 is low, MMA accumulates. MMA is elevated in B12 deficiency but is typically normal in folate deficiency ^[1]. It is the best test of functional B12 status, but can be raised by renal impairment or by rare enzymic defects ^[1]. ^[4][6]

Homocysteine (fasting plasma). Both B12 and folate are cofactors in homocysteine remethylation, so homocysteine rises in either deficiency. It is therefore supportive but not specific: it also rises in folate or vitamin B6 deficiency, chronic kidney disease, hypothyroidism and some genetic variants of methylene tetrahydrofolate reductase ^[1]. It is usually drawn fasting.

Serum folate. The first-line test for folate status ^[3]. It reflects recent intake and absorption, so it can fall within days of poor intake.

Red cell folate. Reflects folate inside red cells and is the alternative when longer-term folate status is wanted. Because the red cell population turns over slowly, it lags behind serum folate.

Intrinsic factor (IF) antibodies and parietal cell antibodies. These are autoimmune tests, not B12 measurements. A positive anti-intrinsic factor antibody supports autoimmune gastritis as the cause of B12 deficiency. Anti-gastric parietal cell antibodies are less specific but can point the same way, and are used when the intrinsic factor antibody is negative ^[1].

Ranges differ by laboratory, by the method and analyser, by age and sex, and by pregnancy status. The values below come from the named sources and are for the tests as quoted; the laboratory's own reference range always wins ^[2]. Conventional units are given where the source or standard conversion gives them.

Notes on special groups:

• In pregnancy, total serum B12 falls as haptocorrin falls, even when there is no true deficiency. Active B12 is the recommended initial test in pregnancy ^[1][2].
• A low total B12 can occur without tissue deficiency when haptocorrin is low, as in pregnancy or with oestrogen-containing drugs; measuring active B12 is then recommended ^[1].
• A high total B12 can mask tissue deficiency when haptocorrin is high, as in acute inflammation, myeloproliferative neoplasms or liver disease, or when anti-intrinsic factor antibodies interfere with the assay ^[1].
• Normal MMA and normal homocysteine exclude vitamin B12 deficiency ^[1].

Named combinations and what each suggests. Guidelines do not agree on which analyte to use first; a comparison of 14 adult anaemia guidelines found only six addressed vitamin B12 or folate thresholds explicitly ^[4].

• Low total and low active B12, elevated MMA and homocysteine: vitamin B12 deficiency confirmed, with the raised MMA pointing at tissue B12 deficiency rather than a low haptocorrin artefact ^[1].
• Low total B12 but normal active B12: often not true tissue deficiency, as in pregnancy or with oestrogen-containing drugs; active B12 is the better guide ^[1].
• Total B12 in the indeterminate range with elevated MMA: functional B12 deficiency despite a borderline serum level; treat and hunt for the cause ^[1][2].
• Normal or high total B12 with elevated MMA: functional deficiency with masking, seen with nitrous oxide, high haptocorrin states, or assay interference from anti-intrinsic factor antibodies ^[1].
• Macrocytic anaemia with hypersegmented neutrophils and low folate, normal B12: folate deficiency ^[6].
• Macrocytic anaemia with both low B12 and low folate: combined deficiency; replace both, but always ensure B12 is covered before giving folate alone ^[6].
• Low serum folate with normal haemoglobin: early depletion, before changes in red cells; a chance to treat before macrocytosis appears.
• Macrocytosis without anaemia (raised MCV, normal haemoglobin): early B12 or folate deficiency, liver disease, alcohol, hypothyroidism, drugs (such as hydroxyurea or methotrexate), or a reticulocytosis; the film and the B12 and folate panel sort these out.
• Normocytic or mixed picture with macrocytosis present: combined iron deficiency can offset the macrocytosis, so a normal MCV does not exclude B12 or folate deficiency when iron deficiency co-exists.

Every value below is invented for teaching. These are illustrative samples, not real patient data. The ranges and the rules used to read them are from the cited sources.

Interpretation:

1. Total B12 and active B12 both sit above the indeterminate band, so B12 deficiency is unlikely ^[2].
2. Serum folate is within the local normal range, so folate deficiency is not supported.
3. MMA and homocysteine are normal, which excludes vitamin B12 deficiency ^[1].
4. The macrocytosis is absent and the film is not described, so no further B12 or folate investigation is needed from this panel.

Clinical conclusion: no current evidence of vitamin B12 or folate deficiency; look for another cause of the patient's presenting complaint.

Interpretation:

1. The low haemoglobin with a raised MCV defines a macrocytic anaemia, and hypersegmented neutrophils on the film would support a megaloblastic process ^[6].
2. Both total and active B12 sit in the deficiency-likely band ^[2].
3. MMA and homocysteine are raised, supporting tissue-level B12 deficiency rather than a low-haptocorrin artefact ^[1].
4. Serum and red cell folate are normal, so an important folate co-deficiency is not present.
5. With this pattern in an adult, autoimmune gastritis (pernicious anaemia) is the leading cause; an anti-intrinsic factor antibody test is the useful next test, followed by parietal cell antibodies or gastrin and gastroscopy if it is negative ^[1].

Clinical conclusion: vitamin B12 deficiency is the cause of the macrocytic anaemia; start parenteral or high-dose oral B12 (in line with the BNF and local guidance) and test for autoimmune gastritis before or alongside treatment. ^[6]

Interpretation:

1. Total and active B12 are not in the deficient band, and not in the clearly normal band: they are indeterminate ^[2].
2. MMA and homocysteine are raised, which supports functional B12 deficiency despite the borderline serum values ^[1][2].
3. Serum folate is normal, so folate deficiency does not explain the homocysteine rise.
4. In an adult with symptoms, this pattern is a reason to start B12 replacement while also addressing the cause, rather than to wait for further drift ^[2].

Clinical conclusion: functional vitamin B12 deficiency on biochemical evidence; replace B12 and investigate for malabsorption, drugs or nitrous oxide exposure.

• Do not read total B12 in isolation. A result in the indeterminate band needs clinical context plus MMA or homocysteine before a deficiency is accepted or excluded ^[1][2].
• A normal MMA and homocysteine excludes vitamin B12 deficiency, but the opposite is not true: a raised MMA or homocysteine does not by itself prove B12 (or folate) deficiency ^[1].
• Folate can correct the anaemia of B12 deficiency without stopping the neuropathy. High-dose folic acid historically restored blood values in undiagnosed B12 deficiency while the B12-related neuropathy progressed ^[6]. Always establish B12 status before giving folate alone. ^[6]
• Low total B12 is not always deficiency (low haptocorrin in pregnancy or on oestrogen), and high total B12 is not always adequacy (high haptocorrin states, or assay interference from anti-intrinsic factor antibodies) ^[1].
• Nitrous oxide inactivates the B12 molecule: total and active B12 can be normal while MMA and homocysteine are high, so choose MMA or homocysteine as the initial test when nitrous oxide use is suspected ^[1][2].
• Recent B12 supplementation, including over-the-counter tablets or injections, can push total and active B12 up without fully correcting tissue deficiency; ask about self-supplementation and interpret with caution ^[2].
• MMA is not specific: chronic kidney disease and rare enzymic defects raise it; homocysteine is not specific either, rising in folate or B6 deficiency, renal impairment and hypothyroidism ^[1].
• Do not forget that B12 deficiency can present with neurological or psychiatric symptoms in the absence of anaemia ^[1].

• Total serum B12 is the first-line test for suspected deficiency; active B12 (holotranscobalamin) is used when the total is indeterminate or during pregnancy ^[1][2].
• Deficiency likely: total B12 under 133 pmol/L (under 180 ng/L); indeterminate: 133 to 258 pmol/L (180 to 350 ng/L); unlikely: over 258 pmol/L (over 350 ng/L) ^[2].
• Active B12 cut-offs: under 25 pmol/L deficient; 25 to 70 indeterminate; over 70 unlikely ^[2].
• MMA is raised in B12 deficiency and normal in folate deficiency; homocysteine rises in both ^[1].
• Normal MMA and homocysteine exclude B12 deficiency ^[1].
• Serum folate is the first-line folate test; it is diagnostically equivalent to red cell folate and is simpler ^[3].
• A low haptocorrin (pregnancy, oestrogen drugs) lowers total B12 without true deficiency; active B12 is the better test ^[1].
• A high haptocorrin (inflammation, myeloproliferative disease, liver disease) or anti-intrinsic factor antibody interference can mask deficiency ^[1].
• Screening for autoimmune gastritis: anti-intrinsic factor antibodies first, then parietal cell antibodies, gastrin or gastroscopy if needed ^[1].
• Folate must not be given alone when B12 status is unknown, because it can correct the blood picture while B12 neuropathy progresses ^[6].
• Deficiency can exist without anaemia, including neurological and psychiatric presentations ^[1].
• Use the laboratory's own reference range for every analyte, including MMA and homocysteine ^[2].